Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 235 | 628 | 2,814 | 3,925 | 5,129 |
| Receivables | 325 | 111 | 0 | 154 | 164 |
| TOTAL | $567 | $759 | $2,814 | $4,102 | $5,371 |
| Non-Current Assets | |||||
| PPE Net | 31 | 1 | N/A | 15,278 | 17,165 |
| Intangibles | N/A | N/A | N/A | 8,377 | 9,648 |
| TOTAL | $31 | $1 | $0 | $23,655 | $26,813 |
| Total Assets | $597 | $760 | $2,814 | $27,757 | $32,184 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 594 | 382 | 0 | 184 | 124 |
| Accrued Expenses | 40 | 19 | 88 | 37 | 56 |
| TOTAL | $711 | $427 | $128 | $259 | $181 |
| Non-Current Liabilities | |||||
| TOTAL | $27 | $0 | $0 | $0 | $0 |
| Total Liabilities | $737 | $427 | $128 | $259 | $181 |
| Shareholders' Equity | |||||
| Common Shares | 83,520 | 89,218 | 93,015 | 82,588 | 95,124 |
| Retained earnings | -85,878 | -88,967 | -90,329 | -55,340 | -64,712 |
| Other shareholders' equity | 2,217 | 82 | 0 | 251 | 1,590 |
| TOTAL | $-140 | $333 | $2,686 | $27,498 | $32,003 |
| Total Liabilities And Equity | $597 | $760 | $2,814 | $27,757 | $32,184 |